Build Your Comparison

Side-by-side financial analysis
FHI logo
FHI
GROW logo
GROW
Try popular comparisons:

Stock Comparison

FHI vs GROW

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
FHI
Federated Hermes, Inc.

Asset Management

Financial ServicesNYSE • US
Market Cap$4.49B
5Y Perf.+149.2%
GROW
U.S. Global Investors, Inc.

Asset Management

Financial ServicesNASDAQ • US
Market Cap$39M
5Y Perf.+63.2%

FHI vs GROW — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
FHI logoFHI
GROW logoGROW
IndustryAsset ManagementAsset Management
Market Cap$4.49B$39M
Revenue (TTM)$1.86B$11M
Net Income (TTM)$399M$3M
Gross Margin51.5%64.9%
Operating Margin27.4%-1.4%
Forward P/E11.6x
Total Debt$457M$83K
Cash & Equiv.$584M$25M

FHI vs GROWLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

FHI
GROW
StockJun 20Jun 26Return
Federated Hermes, I… (FHI)100249.2+149.2%
U.S. Global Investo… (GROW)100163.2+63.2%

Price return only. Dividends and distributions are not included.

Quick Verdict: FHI vs GROW

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: FHI leads in 5 of 7 categories, making it the strongest pick for growth and revenue expansion and profitability and margin quality. U.S. Global Investors, Inc. is the stronger pick specifically for valuation and capital efficiency and dividend income and shareholder returns. As sector peers, any of these can serve as alternatives in the same allocation.
🥇FHI emerged as the overall leader. Track its performance:
FHI
Federated Hermes, Inc.
The Banking Pick

FHI carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.

  • Dividend streak 3 yrs, beta 0.70, yield 2.4%
  • Rev growth 11.0%, EPS growth 58.8%
  • 144.4% 10Y total return vs GROW's 96.0%
Best for: income & stability and growth exposure
GROW
U.S. Global Investors, Inc.
The Banking Pick

GROW is the clearest fit if your priority is value and dividends.

  • Better valuation composite
  • 2.9% yield, vs FHI's 2.4%
Best for: value and dividends
See the full category breakdown
CategoryWinnerWhy
GrowthFHI logoFHI11.0% NII/revenue growth vs GROW's -23.1%
ValueGROW logoGROWBetter valuation composite
Quality / MarginsFHI logoFHIEfficiency ratio 0.4% vs GROW's 0.8% (lower = leaner)
Stability / SafetyFHI logoFHIBeta 0.70 vs GROW's 0.73
DividendsGROW logoGROW2.9% yield, vs FHI's 2.4%
Momentum (1Y)FHI logoFHI+43.1% vs GROW's +31.8%
Efficiency (ROA)FHI logoFHIEfficiency ratio 0.4% vs GROW's 0.8%

FHI vs GROW — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

FHIFederated Hermes, Inc.
FY 2025
Federated Hermes Funds
84.0%$1.5B
Separate accounts
14.2%$256M
Other
1.8%$33M
GROWU.S. Global Investors, Inc.
FY 2025
Investment And Advisory Services
101.5%$8M
Administrative Service
1.5%$127,000
Investment Performance
-3.0%$-247,000

FHI vs GROW — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLFHILAGGINGGROW

Income & Cash Flow (Last 12 Months)

GROW leads this category, winning 3 of 5 comparable metrics.

FHI is the larger business by revenue, generating $1.9B annually — 171.7x GROW's $11M. GROW is the more profitable business, keeping 29.1% of every revenue dollar as net income compared to FHI's 21.4%.

MetricFHI logoFHIFederated Hermes,…GROW logoGROWU.S. Global Inves…
RevenueTrailing 12 months$1.9B$11M
EBITDAEarnings before interest/tax$527M-$111,000
Net IncomeAfter-tax profit$399M$3M
Free Cash FlowCash after capex$307M$464,000
Gross MarginGross profit ÷ Revenue+51.5%+64.9%
Operating MarginEBIT ÷ Revenue+27.4%-1.4%
Net MarginNet income ÷ Revenue+21.4%+29.1%
FCF MarginFCF ÷ Revenue+16.5%+4.3%
Rev. Growth (YoY)Latest quarter vs prior year
EPS Growth (YoY)Latest quarter vs prior year+1.6%+8.8%
GROW leads this category, winning 3 of 5 comparable metrics.

Valuation Metrics

GROW leads this category, winning 2 of 3 comparable metrics.
MetricFHI logoFHIFederated Hermes,…GROW logoGROWU.S. Global Inves…
Market CapShares × price$4.5B$39M
Enterprise ValueMkt cap + debt − cash$4.4B$15M
Trailing P/EPrice ÷ TTM EPS11.51x-124.00x
Forward P/EPrice ÷ next-FY EPS est.11.56x
PEG RatioP/E ÷ EPS growth rate1.19x
EV / EBITDAEnterprise value multiple7.82x
Price / SalesMarket cap ÷ Revenue2.48x4.65x
Price / BookPrice ÷ Book value/share3.51x0.92x
Price / FCFMarket cap ÷ FCF15.23x
GROW leads this category, winning 2 of 3 comparable metrics.

Profitability & Efficiency

FHI leads this category, winning 6 of 9 comparable metrics.

FHI delivers a 29.5% return on equity — every $100 of shareholder capital generates $30 in annual profit, vs $7 for GROW. GROW carries lower financial leverage with a 0.00x debt-to-equity ratio, signaling a more conservative balance sheet compared to FHI's 0.36x. On the Piotroski fundamental quality scale (0–9), FHI scores 8/9 vs GROW's 2/9, reflecting strong financial health.

MetricFHI logoFHIFederated Hermes,…GROW logoGROWU.S. Global Inves…
ROE (TTM)Return on equity+29.5%+7.0%
ROA (TTM)Return on assets+18.2%+6.5%
ROICReturn on invested capital+24.1%-4.7%
ROCEReturn on capital employed+26.3%-6.2%
Piotroski ScoreFundamental quality 0–982
Debt / EquityFinancial leverage0.36x0.00x
Net DebtTotal debt minus cash-$127M-$24M
Cash & Equiv.Liquid assets$584M$25M
Total DebtShort + long-term debt$457M$83,000
Interest CoverageEBIT ÷ Interest expense44.07x776.00x
FHI leads this category, winning 6 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

FHI leads this category, winning 5 of 6 comparable metrics.

A $10,000 investment in FHI five years ago would be worth $20,177 today (with dividends reinvested), compared to $5,846 for GROW. Over the past 12 months, FHI leads with a +43.1% total return vs GROW's +31.8%. The 3-year compound annual growth rate (CAGR) favors FHI at 19.2% vs GROW's 7.0% — a key indicator of consistent wealth creation.

MetricFHI logoFHIFederated Hermes,…GROW logoGROWU.S. Global Inves…
YTD ReturnYear-to-date+14.2%+27.8%
1-Year ReturnPast 12 months+43.1%+31.8%
3-Year ReturnCumulative with dividends+69.2%+22.5%
5-Year ReturnCumulative with dividends+101.8%-41.5%
10-Year ReturnCumulative with dividends+144.4%+96.0%
CAGR (3Y)Annualised 3-year return+19.2%+7.0%
FHI leads this category, winning 5 of 6 comparable metrics.

Risk & Volatility

FHI leads this category, winning 2 of 2 comparable metrics.

FHI is the less volatile stock with a 0.70 beta — it tends to amplify market swings less than GROW's 0.73 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. FHI currently trades 98.7% from its 52-week high vs GROW's 84.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricFHI logoFHIFederated Hermes,…GROW logoGROWU.S. Global Inves…
Beta (5Y)Sensitivity to S&P 5000.70x0.73x
52-Week HighHighest price in past year$59.83$3.65
52-Week LowLowest price in past year$41.71$2.23
% of 52W HighCurrent price vs 52-week peak+98.7%+84.9%
RSI (14)Momentum oscillator 0–10067.268.7
Avg Volume (50D)Average daily shares traded734K28K
FHI leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

Evenly matched — FHI and GROW each lead in 1 of 2 comparable metrics.

For income investors, GROW offers the higher dividend yield at 2.92% vs FHI's 2.36%.

MetricFHI logoFHIFederated Hermes,…GROW logoGROWU.S. Global Inves…
Analyst RatingConsensus buy/hold/sellHold
Price TargetConsensus 12-month target$57.50
# AnalystsCovering analysts21
Dividend YieldAnnual dividend ÷ price+2.4%+2.9%
Dividend StreakConsecutive years of raises30
Dividend / ShareAnnual DPS$1.40$0.09
Buyback YieldShare repurchases ÷ mkt cap+5.9%+5.0%
Evenly matched — FHI and GROW each lead in 1 of 2 comparable metrics.
Key Takeaway

FHI leads in 3 of 6 categories (Profitability & Efficiency, Total Returns). GROW leads in 2 (Income & Cash Flow, Valuation Metrics). 1 tied.

Best OverallFederated Hermes, Inc. (FHI)Leads 3 of 6 categories
Loading custom metrics...

FHI vs GROW: Frequently Asked Questions

8 questions · data-driven answers · updated daily

01

Is FHI or GROW a better buy right now?

For growth investors, Federated Hermes, Inc.

(FHI) is the stronger pick with 11. 0% revenue growth year-over-year, versus -23. 1% for U. S. Global Investors, Inc. (GROW). Federated Hermes, Inc. (FHI) offers the better valuation at 11. 5x trailing P/E (11. 6x forward), making it the more compelling value choice. Analysts rate Federated Hermes, Inc. (FHI) a "Hold" — based on 21 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which is the better long-term investment — FHI or GROW?

Over the past 5 years, Federated Hermes, Inc.

(FHI) delivered a total return of +101. 8%, compared to -41. 5% for U. S. Global Investors, Inc. (GROW). Over 10 years, the gap is even starker: FHI returned +144. 4% versus GROW's +96. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

03

Which is safer — FHI or GROW?

By beta (market sensitivity over 5 years), Federated Hermes, Inc.

(FHI) is the lower-risk stock at 0. 70β versus U. S. Global Investors, Inc. 's 0. 73β — meaning GROW is approximately 5% more volatile than FHI relative to the S&P 500. On balance sheet safety, U. S. Global Investors, Inc. (GROW) carries a lower debt/equity ratio of 0% versus 36% for Federated Hermes, Inc. — giving it more financial flexibility in a downturn.

04

Which is growing faster — FHI or GROW?

By revenue growth (latest reported year), Federated Hermes, Inc.

(FHI) is pulling ahead at 11. 0% versus -23. 1% for U. S. Global Investors, Inc. (GROW). On earnings-per-share growth, the picture is similar: Federated Hermes, Inc. grew EPS 58. 8% year-over-year, compared to -126. 6% for U. S. Global Investors, Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

05

Which has better profit margins — FHI or GROW?

Federated Hermes, Inc.

(FHI) is the more profitable company, earning 22. 3% net margin versus -4. 0% for U. S. Global Investors, Inc. — meaning it keeps 22. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: FHI leads at 29. 5% versus -35. 3% for GROW. At the gross margin level — before operating expenses — FHI leads at 73. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

06

Which pays a better dividend — FHI or GROW?

All stocks in this comparison pay dividends.

U. S. Global Investors, Inc. (GROW) offers the highest yield at 2. 9%, versus 2. 4% for Federated Hermes, Inc. (FHI).

07

Is FHI or GROW better for a retirement portfolio?

For long-horizon retirement investors, Federated Hermes, Inc.

(FHI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 70), 2. 4% yield, +144. 4% 10Y return). Both have compounded well over 10 years (FHI: +144. 4%, GROW: +96. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

08

What are the main differences between FHI and GROW?

Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: FHI is a small-cap deep-value stock; GROW is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.